BLT 0.00% 2.6¢ benitec biopharma limited

Panno thoughts, page-2

  1. 653 Posts.
    lightbulb Created with Sketch. 10
    Peter needs to go. Period. Inept is a perfect description. ddRNAi has attracted no interest by big pharma, another perfectly apt description. Dead money. AGM time is nearing and the entire team needs to be held responsible for their lack of progress in the current trial as well as the disaster that NSCLC is turning into. If there is a plan for this company, other than drawing paychecks, it would be nice to know what it is.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.